SCHEMBL599364

SCHEMBL599364

C=CCOOC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL8026692 0.91 TSHR (0.36)
SCHEMBL905558 0.85
SCHEMBL8021110 0.81 CYP3A4 (0.35)
Bicarbonate SCHEMBL28747310 0.80 CYP3A4 (0.38)
SCHEMBL28747308 0.79 CYP3A4 (0.34)
Bicarbonate SCHEMBL28809113 0.78 TSHR (0.33)
SCHEMBL4958820 0.77
SCHEMBL555029 0.77
SCHEMBL6536969 0.77
SCHEMBL4906830 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1591532-B1 PROCESS FOR PRODUCING SUGAR CHAIN ASPARAGINE DERIVATIVE GLYTECH INC (JP) 2018-10-31 EP claimed
US-9309276-B2 Synthetic lipid A derivative UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2016-04-12 US claimed
US-20140011987-A1 Synthetic Lipid A Derivative UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2014-01-09 US claimed
EP-1405858-B1 PROCESS FOR PRODUCING SUGAR CHAIN ASPARAGINE DERIVATIVE GLYTECH INC (JP) 2013-01-02 EP claimed
WO-2012131077-A1 SOMATOSTATIN MIMETICS NATIONAL UNIVERSITY OF IRELAND, GALWAY (IE) 2012-10-04 WO claimed
US-20110280893-A9 SYNTHETIC LIPID A DERIVATIVE UNIVERSITY OF GEORGIA RESEACH FOUNDATION, INC (US) 2011-11-17 US claimed
US-20100221269-A1 SYNTHETIC LIPID A DERIVATIVE UNIVERSITY OF GEORGIA RESEACH FOUNDATION, INC (US) 2010-09-02 US claimed
WO-2009035528-A2 SYNTHETIC LIPID A DERIVATIVE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2009-03-19 WO claimed
EP-0536969-A2 Anti-endotoxin compounds Eisai Co., Ltd. (JP) 1993-04-14 EP claimed
US-12448470-B2 Polymerizable composition for optical material, molded product, optical material, and plastic lens and method for manufacturing same MITSUI CHEMICALS, INC. (JP) 2025-10-21 US disclosed
US-20250144060-A1 COMPOSITIONS AND METHODS FOR TREATING BIOFILMS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2025-05-08 US disclosed
US-12226386-B2 Compositions and methods for treating biofilms THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-02-18 US disclosed
US-20240423929-A1 EFFECT OF GLYCEROL ON BIOFILM FORMING BACTERIA AND FUNGI THAT CHANGES THE MICROBES SENSITIVITY TO PRO AND ANTI-BIOFILM NON-TOXIC, NON-BONDED PLASMA AMINO ACIDS AND AMINO ACID DERIVATIVES BRYAN THOMAS (US) 2024-12-26 US disclosed
EP-3722840-B1 POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, AND MOLDED ARTICLE MITSUI CHEMICALS INC (JP) 2024-12-04 EP disclosed
WO-1997019129-A1 PROCESS TO PREPARE TWO PHASE FOAM COMPOSITIONS SHELL OIL COMPANY (US) 1997-05-29 WO disclosed
US-5612476-A LIPIDS WITH TETRAHYDROPYRAN GROUPS FOR BACTERICIDES EISAI CO., LTD. (US) 1997-03-18 US disclosed
US-5530113-A TREATING SEPTIC SHOCK, VIRAL INFECTIONS EISAI CO., LTD. (US) 1996-06-25 US disclosed
WO-1996004292-A1 8-FLUORO-ANTHRACYCLINES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. (IT) 1996-02-15 WO disclosed
EP-0552368-A1 PROCESS FOR PURIFYING SYNTHETIC PEPTIDE, AND LINKER AND LINKER-COMBINING SOLID-PHASE CARRIER USED IN SAID PROCESS NIHON MILLIPORE KABUSHIKI KAISHA (JP) 1993-07-28 EP disclosed
EP-0536969-A2 Anti-endotoxin compounds Eisai Co., Ltd. (JP) 1993-04-14 EP disclosed